Louise Rodino-Klapac
Head of R&D and Chief Scientific Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Sarepta Therapeutics, Inc. (SRPT) | President, Research and Development and Technical Operations | $752,505 | $4,456,270 |
| 2024 | Sarepta Therapeutics, Inc. (SRPT) | Executive Vice President, Head of R&D, Chief Scientific Officer | $666,706 | $2,737,283 |
| 2023 | Sarepta Therapeutics, Inc. (SRPT) | Executive Vice President, Head of R&D, Chief Scientific Officer | $641,063 | $3,718,991 |
| 2022 | Sarepta Therapeutics, Inc. (SRPT) | Executive Vice President, Head of R&D, Chief Scientific Officer | $616,962 | $3,941,777 |
| 2021 | Sarepta Therapeutics, Inc. (SRPT) | Executive Vice President, Head of R&D, Chief Scientific Officer | $555,577 | $8,515,533 |
| 2020 | Sarepta Therapeutics, Inc. (SRPT) | Executive Vice President, Head of R&D, Chief Scientific Officer ^^ | $495,590 | $7,269,883 |
| 2019 | Sarepta Therapeutics, Inc. (SRPT) | Executive Vice President, Head of R&D, Chief Scientific Officer ^^ | — | — |
| 2018 | Sarepta Therapeutics, Inc. (SRPT) | Executive Vice President, Chief Scientific Officer ^^ | — | — |
Executive changes
-
Appointed President, Research and Development and Technical Operations at Sarepta Therapeutics, Inc. (SRPT)2025-07-16
Earnings-call appearances
-
Sarepta Therapeutics Second Quarter 2026 Earnings Call2026-08-05
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q2 FY2025 Earnings Call2025-07-16
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q1 FY2025 Earnings Call2025-03-31
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q4 FY2024 Earnings Call2025-02-26
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q3 FY2024 Earnings Call2024-09-30
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q2 FY2024 Earnings Call2024-06-30
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q1 FY2024 Earnings Call2024-03-31
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q4 FY2023 Earnings Call2024-01-08
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q3 FY2023 Earnings Call2023-09-30
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q2 FY2023 Earnings Call2023-06-30
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q1 FY2023 Earnings Call2023-03-31
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q4 FY2022 Earnings Call2023-01-09
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q3 FY2022 Earnings Call2022-09-30
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q2 FY2022 Earnings Call2022-06-30
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q1 FY2022 Earnings Call2022-03-31
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q4 FY2021 Earnings Call2022-01-10
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q3 FY2021 Earnings Call2021-10-15
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q2 FY2021 Earnings Call2021-06-30
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q4 FY2020 Earnings Call2021-01-11
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q2 FY2020 Earnings Call2020-06-30
Sarepta Therapeutics, Inc. (SRPT)
-
Sarepta Therapeutics, Inc. Q1 FY2020 Earnings Call2020-03-31
Sarepta Therapeutics, Inc. (SRPT)